Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2011

Apr 29, 2011

29777_dirs_2011-04-28_873d1c34-bf3c-43aa-aba4-68d9ff5a7c91.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2011-04-26

Reporting Person: AUSTIN ROXANNE S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-04-26 Common shares without par value M 6668 $42.7328 Acquired 25748 Direct
2011-04-26 Common shares without par value S 4168 $51.366 Disposed 21580 Direct
2011-04-26 Common shares without par value S 2500 $51.361 Disposed 19080 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-04-26 Option (right to buy) $42.7328 M 6668 Disposed 2011-04-26 Common Shares (6668) Direct

Footnotes

F1: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.